Episode 22-37 Long Covid – Biotech is working on it

On this week’s Tech Nation, Moira speaks with Dr. Jeffrey Cleland, the President & CEO of Ashvattha Therapeutics, about their drug development efforts to treat Long Covid. Then Dr. Greg Frost, the Chair and CEO of Exuma Biotech, tells us about their work to speed up CAR-T – from 4-6 weeks to just a few hours, and a second delivery method – programming a virus to produce the treatment protein needed. Just a simple injection under the skin. Finally, Wall Street Journal reporter Katherine Blunt with “California Burning … The Fall of Pacific Gas and Electric – and What It Means for America’s Power Grid”. What’s causing many of those California wildfires? Aging Technology.